| Year |
Citation |
Score |
| 2024 |
Oróstica K, Mardones F, Bernal YA, Molina S, Orchard M, Verdugo RA, Carvajal-Hausdorf D, Marcelain K, Contreras S, Armisen R. Advances in machine learning for tumour classification in cancer of unknown primary: A mini-review. Cancer Letters. 611: 217348. PMID 39613220 DOI: 10.1016/j.canlet.2024.217348 |
0.645 |
|
| 2024 |
Araya C, Mino B, Le Cerf P, Gaete F, Armisen R, Carvajal-Hausdorf DE. Molecular Analysis of PIK3CA in Metastatic Hormone Receptor-Positive Breast Cancer in Chile: Clinical and Pathological Insights. International Journal of Molecular Sciences. 25. PMID 39596311 DOI: 10.3390/ijms252212246 |
0.302 |
|
| 2024 |
Garrido J, Bernal Y, González E, Blanco A, Sepúlveda-Hermosilla G, Freire M, Oróstica K, Rivas S, Marcelain K, Owen G, Ibañez C, Corvalan A, Garrido M, Assar R, Lizana R, et al. Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers. Bmc Cancer. 24: 951. PMID 39097719 DOI: 10.1186/s12885-024-12737-1 |
0.707 |
|
| 2024 |
Bernal YA, Durán E, Solar I, Sagredo EA, Armisén R. ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer. International Journal of Molecular Sciences. 25. PMID 39000531 DOI: 10.3390/ijms25137424 |
0.781 |
|
| 2024 |
Tapia-Valladares C, Valenzuela G, González E, Maureira I, Toro J, Freire M, Sepúlveda-Hermosilla G, Ampuero D, Blanco A, Gallegos I, Morales F, Erices JI, Barajas O, Ahumada M, Contreras HR, et al. Distinct Driver Pathway Enrichments and a High Prevalence of Mutations in Right Colon Cancer in Chile: A Preliminary Comparative Analysis. International Journal of Molecular Sciences. 25. PMID 38731914 DOI: 10.3390/ijms25094695 |
0.759 |
|
| 2024 |
Bernal YA, Blanco A, Sagredo EA, Oróstica K, Alfaro I, Marcelain K, Armisén R. A Comprehensive Analysis of the Effect of A>I(G) RNA-Editing Sites on Genotoxic Drug Response and Progression in Breast Cancer. Biomedicines. 12. PMID 38672084 DOI: 10.3390/biomedicines12040728 |
0.795 |
|
| 2022 |
Rivas S, Marín A, Samtani S, González-Feliú E, Armisén R. MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies. International Journal of Molecular Sciences. 23. PMID 36430388 DOI: 10.3390/ijms232213898 |
0.794 |
|
| 2022 |
Oróstica KY, Saez-Hidalgo J, de Santiago PR, Rivas S, Contreras S, Navarro G, Asenjo JA, Olivera-Nappa Á, Armisén R. Total mutational load and clinical features as predictors of the metastatic status in lung adenocarcinoma and squamous cell carcinoma patients. Journal of Translational Medicine. 20: 373. PMID 35982500 DOI: 10.1186/s12967-022-03572-8 |
0.788 |
|
| 2022 |
Morales F, Pérez P, Tapia JC, Lobos-González L, Herranz JM, Guevara F, de Santiago PR, Palacios E, Andaur R, Sagredo EA, Marcelain K, Armisén R. Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells. Gene. 819: 146246. PMID 35122924 DOI: 10.1016/j.gene.2022.146246 |
0.775 |
|
| 2022 |
Torres M, Castillo K, Armisén R, Stutzin A, Soto C, Hetz C. Correction: Prion Protein Misfolding Affects Calcium Homeostasis and Sensitizes Cells to Endoplasmic Reticulum Stress. Plos One. 17: e0262628. PMID 35015786 DOI: 10.1371/journal.pone.0262628 |
0.212 |
|
| 2021 |
Salvo M, González-Feliú E, Toro J, Gallegos I, Maureira I, Miranda-González N, Barajas O, Bustamante E, Ahumada M, Colombo A, Armisén R, Villamán C, Ibañez C, Bravo ML, Sanhueza V, et al. Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America. Journal of Personalized Medicine. 11. PMID 34575676 DOI: 10.3390/jpm11090899 |
0.674 |
|
| 2021 |
Cordova-Delgado M, Bravo ML, Cumsille E, Hill CN, Muñoz-Medel M, Pinto MP, Retamal IN, Lavanderos MA, Miquel JF, Rodriguez-Fernandez M, Liao Y, Li Z, Corvalán AH, Armisén R, Garrido M, et al. A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer. Bmc Cancer. 21: 1030. PMID 34525956 DOI: 10.1186/s12885-021-08745-0 |
0.303 |
|
| 2021 |
Rodriguez DA, Zamorano S, Lisbona F, Rojas-Rivera D, Urra H, Cubillos-Ruiz JR, Armisen R, Henriquez DR, Cheng EH, Letek M, Vaisar T, Irrazabal T, Gonzalez-Billault C, Letai A, Pimentel-Muiños FX, et al. BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α. The Embo Journal. 40: e109146. PMID 34523136 DOI: 10.15252/embj.2021109146 |
0.211 |
|
| 2021 |
Sepúlveda-Hermosilla G, Freire M, Blanco A, Cáceres J, Lizana R, Ramos L, Assar R, Ampuero D, Aren O, Chernilo S, Spencer ML, Bernal G, Flores J, Rasse G, Sánchez C, et al. Concordance analysis of ALK gene fusion detection methods in patients with Non-Small-Cell Lung Cancer from Chile, Brazil, and Peru. The Journal of Molecular Diagnostics : Jmd. PMID 34186175 DOI: 10.1016/j.jmoldx.2021.05.018 |
0.782 |
|
| 2021 |
Toledo-Stuardo K, Ribeiro CH, Canals A, Morales M, Gárate V, Rodríguez-Siza J, Tello S, Bustamante M, Armisen R, Matthies DJ, Zapata-Torres G, González-Hormazabal P, Molina MC. Major Histocompatibility Complex Class I-Related Chain A (MICA) Allelic Variants Associate With Susceptibility and Prognosis of Gastric Cancer. Frontiers in Immunology. 12: 645528. PMID 33868281 DOI: 10.3389/fimmu.2021.645528 |
0.743 |
|
| 2020 |
de Santiago PR, Blanco A, Morales F, Marcelain K, Harismendy O, Herrera MS, Armisén R. Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis. Life Sciences. 118956. PMID 33383047 DOI: 10.1016/j.lfs.2020.118956 |
0.78 |
|
| 2020 |
Sagredo EA, Sagredo AI, Blanco A, De Santiago PR, Rivas S, Assar R, Pérez P, Marcelain K, Armisén R. ADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage response. Biochimica Et Biophysica Acta. Molecular Cell Research. 118716. PMID 32275931 DOI: 10.1016/J.Bbamcr.2020.118716 |
0.782 |
|
| 2020 |
Cappelli C, Sepulveda H, Rivas S, Pola V, Urzúa U, Donoso G, Sagredo E, Carrero D, Casanova-Ortiz E, Sagredo A, González M, Manterola M, Nardocci G, Armisén R, Montecino M, et al. Ski Is Required for Tri-Methylation of H3K9 in Major Satellite and for Repression of Pericentromeric Genes: Mmp3, Mmp10 and Mmp13, in Mouse Fibroblasts. Journal of Molecular Biology. PMID 32198114 DOI: 10.1016/J.Jmb.2020.03.013 |
0.743 |
|
| 2019 |
Cordova-Delgado M, Pinto MP, Retamal IN, Muñoz-Medel M, Bravo ML, Fernández MF, Cisternas B, Mondaca S, Sanchez C, Galindo H, Nervi B, Ibáñez C, Acevedo F, Madrid J, Peña J, et al. High Proportion of Potential Candidates for Immunotherapy in a Chilean Cohort of Gastric Cancer Patients: Results of the FORCE1 Study. Cancers. 11. PMID 31480291 DOI: 10.3390/Cancers11091275 |
0.461 |
|
| 2019 |
Pinto MP, Retamal IN, Bravo ML, Muñoz-Medel M, Cordova-Delgado M, Romero D, Maturana MJ, Jara NDL, Torres J, Espinoza M, Balmaceda C, Freire M, Garate-Calderon V, Caceres-Molina J, Sepulveda-Hermosilla G, ... ... Armisen R, et al. Abstract 3102: The Chilean gastric cancer task force: Final report Cancer Research. 79: 3102-3102. DOI: 10.1158/1538-7445.Am2019-3102 |
0.496 |
|
| 2018 |
Sagredo AI, Sagredo EA, Pola V, Echeverría C, Andaur R, Michea L, Stutzin A, Simon F, Marcelain K, Armisén R. TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines. Journal of Cellular Physiology. PMID 30343491 DOI: 10.1002/Jcp.27371 |
0.782 |
|
| 2018 |
Sagredo EA, Blanco A, Sagredo AI, Pérez P, Sepúlveda-Hermosilla G, Morales F, Müller B, Verdugo R, Marcelain K, Harismendy O, Armisén R. ADAR1-mediated RNA-editing of 3'UTRs in breast cancer. Biological Research. 51: 36. PMID 30290838 DOI: 10.1186/S40659-018-0185-4 |
0.758 |
|
| 2018 |
Andaur R, Tapia JC, Moreno J, Soto L, Armisen R, Marcelain K. Differential miRNA expression profiling reveals miR-205-3p to be a potential radiosensitizer for low- dose ionizing radiation in DLD-1 cells. Oncotarget. 9: 26387-26405. PMID 29899866 DOI: 10.18632/Oncotarget.25405 |
0.666 |
|
| 2018 |
Owen GI, Pinto MP, Retamal IN, Fernádez MF, Cisternas B, Mondaca S, Sanchez C, Galindo H, Nervi B, Ibañez C, Acevedo F, Madrid J, Peña J, Bravo ML, Maturana MJ, ... ... Armisen R, et al. Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients. Medicine. 97: e0419. PMID 29668600 DOI: 10.1097/Md.0000000000010419 |
0.472 |
|
| 2018 |
Koch EC, Pinto MP, Retamal IN, Bravo ML, Maturana MJ, Cordova-Delgado M, Romero D, Jara NDL, Torres J, Espinoza M, Balmaceda C, Freire M, Garate-Calderon V, Avila R, Crovari F, ... ... Armisen R, et al. Abstract 694: The Chilean Gastric Cancer Task Force: An update of results Immunology. DOI: 10.1158/1538-7445.Am2018-694 |
0.391 |
|
| 2018 |
Jain J, Moreno J, Andaur R, Armisen R, Avaria G, Bora B, Davis S, Pavez C, Marcelain K, Soto L. In vitro irradiation of colorectal cancer cells by pulsed radiation emitted from a hundred joules plasma focus device and its comparison with continuous irradiation Journal of Physics: Conference Series. 1043: 012047. DOI: 10.1088/1742-6596/1043/1/012047 |
0.666 |
|
| 2017 |
Simon F, Tapia P, Armisen R, Echeverria C, Gatica S, Vallejos A, Pacheco A, Sanhueza ME, Alvo M, Segovia E, Torres R. Human Peritoneal Mesothelial Cell Death Induced by High-Glucose Hypertonic Solution Involves Ca(2+) and Na(+) Ions and Oxidative Stress with the Participation of PKC/NOX2 and PI3K/Akt Pathways. Frontiers in Physiology. 8: 379. PMID 28659813 DOI: 10.3389/Fphys.2017.00379 |
0.701 |
|
| 2017 |
Sagredo AI, Sagredo EA, Cappelli C, Báez P, Rodrigo AM, Blanco C, Tapia JC, Echeverría C, Cerda O, Stutzin A, Simon F, Marcelain K, Armisén R. TRPM4 regulates Akt/GSK3-β activity and enhances β-catenin signaling and cell proliferation in prostate cancer cells. Molecular Oncology. PMID 28614631 DOI: 10.1002/1878-0261.12100 |
0.754 |
|
| 2017 |
Jain J, Moreno J, Andaur R, Armisen R, Morales D, Marcelain K, Avaria G, Bora B, Davis S, Pavez C, Soto L. Hundred joules plasma focus device as a potential pulsed source for in vitro cancer cell irradiation Aip Advances. 7: 085121. DOI: 10.1063/1.4994655 |
0.685 |
|
| 2016 |
Echeverría C, Romero V, Arancibia R, Klahn H, Montorfano I, Armisen R, Borgna V, Simon F, Ramirez-Tagle R. The characterization of anti-T. cruzi activity relationships between ferrocenyl, cyrhetrenyl complexes and ROS release. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. PMID 27460450 DOI: 10.1007/S10534-016-9953-1 |
0.686 |
|
| 2016 |
Levy E, Marty R, Gárate Calderón V, Woo B, Dow M, Armisen R, Carter H, Harismendy O. Immune DNA signature of T-cell infiltration in breast tumor exomes. Scientific Reports. 6: 30064. PMID 27452728 DOI: 10.1038/Srep30064 |
0.488 |
|
| 2016 |
Ramirez-Tagle R, Escobar CA, Romero V, Montorfano I, Armisén R, Borgna V, Jeldes E, Pizarro L, Simon F, Echeverria C. Chalcone-Induced Apoptosis through Caspase-Dependent Intrinsic Pathways in Human Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences. 17. PMID 26907262 DOI: 10.3390/Ijms17020260 |
0.719 |
|
| 2016 |
Woehlbier U, Colombo A, Saaranen MJ, Pérez V, Ojeda J, Bustos FJ, Andreu CI, Torres M, Valenzuela V, Medinas DB, Rozas P, Vidal RL, Lopez-Gonzalez R, Salameh J, Fernandez-Collemann S, ... ... Armisen R, et al. ALS-linked protein disulfide isomerase variants cause motor dysfunction. The Embo Journal. PMID 26869642 DOI: 10.15252/Embj.201592224 |
0.768 |
|
| 2016 |
Jain J, Moreno J, Avaria G, Pavez C, Bora B, Izurieta MJI, Diez D, Alvarez O, Tapia J, Marcelain K, Armisen R, Soto L. Characterization of x-rays pulses from a hundred joules plasma focus to study its effects on cancer cells. Journal of Physics: Conference Series. 720: 012043. DOI: 10.1088/1742-6596/720/1/012043 |
0.67 |
|
| 2016 |
Bora B, Jain J, Inestrosa-Izurieta MJ, Avaria G, Moreno J, Pavez C, Marcelain K, Armisen R, Soto L. Development of plasma needle to be used for biomedical applications Journal of Physics: Conference Series. 720: 012038. DOI: 10.1088/1742-6596/720/1/012038 |
0.613 |
|
| 2015 |
Niechi I, Silva E, Cabello P, Huerta H, Carrasco V, Villar P, Cataldo LR, Marcelain K, Armisen R, Varas-Godoy M, Fernandez C, Tapia JC. Colon cancer cell invasion is promoted by protein kinase CK2 through increase of endothelin-converting enzyme-1c protein stability. Oncotarget. PMID 26543229 DOI: 10.18632/Oncotarget.5722 |
0.721 |
|
| 2015 |
Rivas S, Armisén R, Rojas DA, Maldonado E, Huerta H, Tapia JC, Espinoza J, Colombo A, Michea L, Hayman MJ, Marcelain K. The Ski Protein is Involved in the Transformation Pathway of Aurora Kinase A. Journal of Cellular Biochemistry. PMID 26138431 DOI: 10.1002/Jcb.25275 |
0.793 |
|
| 2015 |
Echeverría C, Montorfano I, Cabello-Verrugio C, Armisén R, Varela D, Simon F. Suppression of transient receptor potential melastatin 4 expression promotes conversion of endothelial cells into fibroblasts via transforming growth factor/activin receptor-like kinase 5 pathway. Journal of Hypertension. 33: 981-92. PMID 25909699 DOI: 10.1097/Hjh.0000000000000496 |
0.702 |
|
| 2014 |
Simon F, Echeverria C, Montorfano I, Becerra A, Varela D, Hermosilla T, Cabello-Verrugio C, Armisen R. P173Vascular endothelial fibrosis induced by endotoxin: characteristics, mechanism and therapeutic perspectives Cardiovascular Research. 103: S30.4-S30. DOI: 10.1093/Cvr/Cvu082.109 |
0.47 |
|
| 2014 |
González C, Armisén R, Stutzin A, Baez P, Landerer E, Paredes R, Contreras I, Muñoz C. Mast Cell Infiltration and Kit and Protease Expression During Progression of a Transgenic Prostate Cancer Murine Model (TRAMP) Journal of Comparative Pathology. 150: 88. DOI: 10.1016/j.jcpa.2013.11.051 |
0.349 |
|
| 2013 |
Yefi R, Silva E, Cabello P, Niechi I, Huerta H, Armisen R, Fernandez C, Tapia JC. Abstract A59: Protein kinase CK2 regulates β-catenin association to E-cadherin and hence viability and invasion of colorectal cancer cells Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-A59 |
0.529 |
|
| 2012 |
Rodriguez DA, Zamorano S, Lisbona F, Rojas-Rivera D, Urra H, Cubillos-Ruiz JR, Armisen R, Henriquez DR, Cheng EH, Letek M, Vaisar T, Irrazabal T, Gonzalez-Billault C, Letai A, Pimentel-Muiños FX, et al. BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α. The Embo Journal. 31: 2322-35. PMID 22510886 DOI: 10.1038/Emboj.2012.84 |
0.38 |
|
| 2012 |
Marcelain K, Armisen R, Aguirre A, Ueki N, Toro J, Colmenares C, Hayman MJ. Chromosomal instability in mouse embryonic fibroblasts null for the transcriptional co-repressor Ski. Journal of Cellular Physiology. 227: 278-87. PMID 21412778 DOI: 10.1002/Jcp.22733 |
0.704 |
|
| 2011 |
Ponce DP, Yefi R, Cabello P, Maturana JL, Niechi I, Silva E, Galindo M, Antonelli M, Marcelain K, Armisen R, Tapia JC. CK2 functionally interacts with AKT/PKB to promote the β-catenin-dependent expression of survivin and enhance cell survival. Molecular and Cellular Biochemistry. 356: 127-32. PMID 21735093 DOI: 10.1007/S11010-011-0965-4 |
0.707 |
|
| 2011 |
Yefi R, Ponce DP, Niechi I, Silva E, Cabello P, Rodriguez DA, Marcelain K, Armisen R, Quest AF, Tapia JC. Protein kinase CK2 promotes cancer cell viability via up-regulation of cyclooxygenase-2 expression and enhanced prostaglandin E2 production. Journal of Cellular Biochemistry. 112: 3167-75. PMID 21732411 DOI: 10.1002/Jcb.23247 |
0.752 |
|
| 2011 |
Mosquera J, Armisen R, Zhao H, Rojas DA, Maldonado E, Tapia JC, Colombo A, Hayman MJ, Marcelain K. Identification of Ski as a target for Aurora A kinase. Biochemical and Biophysical Research Communications. 409: 539-43. PMID 21600873 DOI: 10.1016/J.Bbrc.2011.05.040 |
0.683 |
|
| 2011 |
Ponce DP, Maturana JL, Cabello P, Yefi R, Niechi I, Silva E, Armisen R, Galindo M, Antonelli M, Tapia JC. Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of β-catenin transcriptional activity. Journal of Cellular Physiology. 226: 1953-9. PMID 21506126 DOI: 10.1002/Jcp.22527 |
0.445 |
|
| 2008 |
Gonzalez-Zeh R, Armisen R, Barahona S. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results. Journal of Vascular Surgery. 48: 940-6. PMID 18639418 DOI: 10.1016/J.Jvs.2008.05.062 |
0.324 |
|
| 2007 |
Armisen R, Gleason MR, Fetcho JR, Mandel G. Tracking tagged molecules in single neurons in intact zebrafish. Csh Protocols. 2007: pdb.prot4780. PMID 21357144 DOI: 10.1101/Pdb.Prot4780 |
0.756 |
|
| 2006 |
OlguÃn P, Armisen R, Kukuljan M. Developmental regulation of the expression of sodium currents in Xenopus primary neurons. Biological Research. 39: 483-91. PMID 17106580 DOI: 10.4067/S0716-97602006000300010 |
0.664 |
|
| 2004 |
Gleason MR, Armisen R, Verdecia MA, Sirotkin H, Brehm P, Mandel G. A mutation in serca underlies motility dysfunction in accordion zebrafish. Developmental Biology. 276: 441-51. PMID 15581877 DOI: 10.1016/J.Ydbio.2004.09.008 |
0.759 |
|
| 2002 |
Armisén R, Fuentes R, Olguı́n P, Cabrejos ME, Kukuljan M. Repressor Element-1 Silencing Transcription/Neuron-Restrictive Silencer Factor Is Required for Neural Sodium Channel Expression during Development ofXenopus The Journal of Neuroscience. 22: 8347-8351. DOI: 10.1523/JNEUROSCI.22-19-08347.2002 |
0.63 |
|
| 1996 |
Armisén R, Sierralta J, Vélez P, Naranjo D, Suárez-Isla BA. Modal gating in neuronal and skeletal muscle ryanodine-sensitive Ca2+ release channels. The American Journal of Physiology. 271: C144-53. PMID 8760040 DOI: 10.1152/Ajpcell.1996.271.1.C144 |
0.324 |
|
| Show low-probability matches. |